Basal and Adrenocorticotropic Hormone Stimulated Plasma Cortisol Levels Among Egyptian Autistic Children: Relation to Disease Severity by Hamza, Rasha T et al.
RESEARCH Open Access
Basal and Adrenocorticotropic Hormone Stimulated
Plasma Cortisol Levels Among Egyptian Autistic
Children: Relation to Disease Severity
Rasha T Hamza
1*, Doaa H Hewedi
2, Mona A Ismail
3
Abstract
Background: Autism is a disorder of early childhood characterized by social impairment, communication
abnormalities and stereotyped behaviors. The hypothalamic-pituitary-adrenocortical (HPA) axis deserves special
attention, since it is the basis for emotions and social interactions that are affected in autism.
Aim: To assess basal and stimulated plasma cortisol, and adrenocorticotropic hormone (ACTH) levels in autistic
children and their relationship to disease characteristics.
Methods: Fifty autistic children were studied in comparison to 50 healthy age-, sex- and pubertal stage- matched
children. All subjects were subjected to clinical evaluation and measurement of plasma cortisol (basal and
stimulated) and ACTH. In addition, electroencephalography (EEG) and intelligence quotient (IQ) assessment were
done for all autistic children.
Results: Sixteen% of autistic patients had high ACTH, 10% had low basal cortisol and 10% did not show adequate
cortisol response to ACTH stimulation. Autistic patients had lower basal (p = 0.032) and stimulated cortisol (p =
0.04) and higher ACTH (p = 0.01) than controls. Childhood Autism Rating Scale (CARS) score correlated positively
with ACTH (r = 0.71, p = 0.02) and negatively with each of basal (r = -0.64, p = 0.04) and stimulated cortisol (r =
-0.88, p < 0.001). Hormonal profile did not differ in relation to EEG abnormalities, IQ and self- aggressive symptoms.
Conclusions: The observed hormonal changes may be due to a dysfunction in the HPA axis in autistic individuals.
Further studies are warranted regarding the role of HPA axis dysfunction in the pathogenesis of autism.
Introduction
Despite the fact that autism was described more than 60
years ago, its etiology remains a mystery [1-5]. Many
genetic studies [6-8], hormone and neurotransmitter
analysis [9-15], did not find a reasonable explanation for
the mechanisms underlying development of autism.
Lesions of different brain regions, including the limbic
system, have been implicated in the development of aut-
ism [12,16]. The HPA axis deserves special attention,
since it is the basis for emotions and social interactions,
that are affected in autism [12,13,15,17].
One of the approaches to test the HPA axis is a mea-
surement of its hormones and their subsequent targets
together with the rapid ACTH stimulation test [18,19].
Studies regarding abnormalities in the HPA axis in
autistic patients showed conflicting results [20-22].
With this background, this study was conducted to
assess plasma cortisol (morning basal and ACTH stimu-
lated), and ACTH levels in autistic children and adoles-
cents and their relationship to disease characteristics in
terms of disease severity, IQ, EEG abnormalities and
self-aggressive behaviour.
Subjects and Methods
This cross sectional case-control study was conducted on
50 autistic children and adolescents diagnosed according
to the 4
th edition of Diagnostic and Statistical Manual of
Mental Disorders (DSM IV) [23]. Patients were recruited
from the Institute of Psychiatry (n = 36) and Pediatric
Psychiatry Clinic, Children’s hospital (n = 14), Faculty of
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period from the beginning of May 2009 to the end of
November 2009. They were 40 males and 10 females
with a male: female ratio of 4:1. Their ages ranged
between 3 and 12 years with a mean age of 7.35 ± 2.6
years. None of the patients had underlying conditions
apart from autism (syndromic causes, chromosomal or
metabolic abnormalities) that could influence HPA axis
function independently of autism.
Autistic patients were studied in comparison to 50
healthy age-, sex- and pubertal stage- matched children
and adolescents serving as controls. The latter had no
clinical findings suggesting neuropsychiatric manifesta-
tions nor endocrine abnormalities in particular adreno-
cortical function (normal blood pressure, normal serum
sodium, potassium and random blood sugar). None of
the studied subjects were taking medications that might
influence the HPA axis.
An informed written consent of participation in the
study was signed by the parents or legal guardians of
the studied subjects. This study was approved by the
Bioethical Research Committee, Faculty of Medicine,
Ain Shams University hospitals, Cairo, Egypt.
All studied children were subjected to
1) Medical history taken from the patients’ caregivers
laying stress on developmental history and history sug-
gestive of adrenocortical dysfunction e.g weakness, fati-
gue, anorexia, nausea, vomiting.
2) Physical examination especially hyperpigmentation
of skin and/or mucous membranes (due to high ACTH)
and Tanner staging for assessment of pubertal status
according to the standards of Tanner and Whitehouse
[24].
3) Neuropsychiatric assessment (for patients only):
▪ Diagnosis of autism using DSM IV criteria [23].
▪ The severity of autism was evaluated using Child-
hood Autism Rating Scale “CARS” [25] which rates
t h ec h i l do nas c a l ef r o mo n et of o u ri ne a c ho f1 5
areas (relating to people; emotional response; imita-
tion; body use; object use; listening response; fear or
nervousness; verbal communication; non-verbal
communication; activity level; level and consistency
of intellectual response; adaptation to change; visual
response; taste, smell and touch response and gen-
eral impressions). According to the scale, scores of
30-36 indicate mild to moderate autism and scores
of 37-60 indicate severe autism.
▪ IQ assessment using Wechsler Intelligence
Scale for Children (WISC): [26]
Cognitive function (memory, attention, language, con-
cept formation, problem solving, executive and
visuospatial functions) was assessed with age-appropri-
ate, translated and validated psychometric instruments
that were administered by a well-trained psychologist.
This scale is the most commonly used test to assess
cognitive function in children. It measures verbal IQ
(information and general knowledge, comprehension,
arithmetic abilities, similarities to measure abstraction,
vocabulary and digit span), performance IQ (picture
completion for visuoperceptive defects, block design to
measure left-right dominance, picture arrangement to
measure subject’s cognitive style, object assembly to
measure organization and digit symbol) and full scale
IQ. Subnormal intellectual function is diagnosed when
IQ is below 70.
▪ History of self-aggressive behaviour including pull-
ing their hair, ears and scratching their skin.
4) Measurement of regional brain electrical activity
of autistic children. This was done by using inter-ictal
EEG (for patients only).
5) Laboratory investigations:
▪ Fasting morning plasma cortisol (9:00 am)
▪ Fasting morning plasma ACTH (9:00 am)
Plasma cortisol and ACTH were assayed by a single
person blind to the clinical conditions of the patients
using Siemens cortisol and ACTH kits with the Immu-
lite 2000 Analyzer using chemiluminescent immuno-
metric assay [27]. Reference age- and sex- matched
values for basal plasma cortisol ranged between 7-
25 ug/dl while those for plasma ACTH ranged between
10-48 pg/ml.
▪ Rapid ACTH stimulation test: A synthetic human
ACTH is used, fasting is not required and the test
can be performed at any time of the day. A baseline
cortisol sample is obtained and ACTH is adminis-
tered in a dose of 0.25 mg intravenously and another
sample for plasma cortisol is obtained at 60 minutes
following the injection. Normally, the plasma cortisol
response at 60 minutes post injection should reach
≥ 18 ug/dl [18].
Statistical analysis
The results were analyzed using the Statistical Package
for the Social Science (SPSS) version number 10, Echo-
soft corp; USA, 2005. Description of quantitative vari-
ables was in the form of mean ± standard deviation and
range while that of qualitative variables was in the form
of frequency and percentage. Chi-square test was used
to compare 2 qualitative data. Student’st - t e s to f2
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tive variables while paired t-test was used to compare
plasma cortisol levels before and after ACTH stimula-
tion. Pearson correlation coefficient test (r-test) was
used to rank different variables against each other either
directly or indirectly. A p value of < 0.05 was considered
significant.
Results
Of 50 studied patients, 29 (58%) were pre-pubertal, 13
(26%) were in Tanner stage 2, 7 (14%) were in Tanner
stage 3 and 1 (2%) was in Tanner stage 4 which is ear-
lier than what is normally expected for age because
similar to the known combination of central nervous
system disorders and precocious puberty, patients with
autism may be susceptible to early onset of puberty
[28]. Regarding autistic severity measured by CARS; 26
patients (52%) were of mild to moderate severity (18
males and 8 females) and 24 (48%) were severely autistic
(22 males and 2 females).
None of our patients had history suggestive of adreno-
cortical dysfunction nor hyperpigmentation of the skin
and/or mucous membranes. The mean values of all hor-
monal parameters among the whole sample were within
normal reference ranges [Table 1]. Eight patients (16%)
had a higher plasma ACTH than age- and sex- matched
reference ranges, 5/50 (10%) had a lower plasma cortisol
than age- and sex- matched reference ranges and 5/50
(10%) did not show adequate cortisol response to
ACTH stimulation, that is, a cortisol level of < 18 ug/dl
60 minutes after ACTH injection. Autistic children had
lower morning basal cortisol (p = 0.032), higher ACTH
(p = 0.01) and lower cortisol response after ACTH sti-
mulation (p = 0.04) when compared to healthy age-,
sex- and pubertal stage- matched controls [Table 1].
Moreover, significantly lower morning basal cortisol
(p = 0.041), higher ACTH (p = 0.033) and lower cortisol
response after ACTH stimulation (p = 0.04) were
encountered as the autistic severity increased [Table 2].
In addition, CARS score correlated positively with
ACTH (r = 0.71, p = 0.02) and negatively with each of
basal cortisol (r = - 0.64, p = 0.04) and cortisol after
ACTH stimulation (r = - 0.88, p < 0.001, Figure 1).
Thirty three of our 50 autistic children (66%) had sub-
normal intellectual function (IQ below 70) among
whom 25 (50%) had mild mental retardation (IQ = 50-
69) and 8 (16%) had moderate mental retardation (IQ =
35-49). Of the 33 retarded patients, 20 (60.6%) had
severe autism and the remaining 13 (39.4%) had mild to
moderate autism. On comparing cortisol (basal and
ACTH stimulated) & ACTH levels in relation to IQ of
autistic patients, all hormonal parameters did not differ
significantly according to the IQ of autistic children
(p > 0.05).
EEG abnormalities were found in 20/50 (40%) of
autistic children (14 had severe autism and 6 had mild
to moderate autism). These abnormalities included focal
epileptogenic activity in frontal or temporal lobes in 10
patients, generalized epileptogenic activity in 6 patients
and immature background in the remaining 4 patients.
None of the hormones differed between autistic children
with (n = 20) and without EEG abnormalities (n = 30,
p > 0.05).
Also, none of the hormones differed between autistic
subjects with (n = 16) and without (n = 34) self-aggres-
sive symptoms and among different Tanner stages (p >
0.05).
Discussion
Autism is a disorder of early childhood characterized by
social impairment, communication abnormalities and
stereotyped behaviours [23]. Inspite of the fact that
Table 1 Comparison of basal and ACTH stimulated plasma cortisol, and ACTH levels among autistic patients and
controls
Patients Controls t p
Morning basal cortisol
(ug/dl)
11.02 ± 5.23
(2.41-19.29)
18.94 ± 3.05
(10.32-24.10)
5.67 0.032*
Morning ACTH
(Pg/ml)
31.89 ± 10.17
(18.82-56.24)
21.89 ± 6.15
(12.67-34.21)
6.28 0.01*
Cortisol 60 minutes after ACTH stimulation (ug/dl) 22.92 ± 3.12
(14.38-28.08)
27.01 ± 2.19
(18.23 ± 32.81)
4.39 0.04*
Results are expressed as mean± SD and range, p < 0.05*: significant, ACTH: adrenocorticotropic hormone.
Table 2 Relationship between hormonal profile and
autistic severity
Mild to moderate
(n = 26)
Severe
(n = 24)
tp
Morning basal cortisol
(ug/dl)
12.96 ± 4.28
(5.32-19.29)
8.15 ± 4.14
(2.41-16.32)
3.90 0.041*
Morning ACTH
(Pg/ml)
26.94 ± 5.02
(18.82-49.61)
33.83 ± 6.08
(20.89-56.24)
4.32 0.033*
Cortisol 60 minutes
after ACTH
stimulation (ug/dl)
23.42 ± 4.01
(17.10-28.08)
19.94 ± 1.89
(14.38-22.92)
5.29 0.040*
Results are expressed as mean± SD and range, P < 0.05*: significant, ACTH:
adrenocorticotropic hormone.
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basis of this disorder, its cause remains obscure [21].
The limbic system deserves special attention in autism
because this brain region is a basis for emotions and
social interactions (which are abnormal in autism).
Since the limbic system influences the functions of the
hypothalamus and the pituitary gland, it is logical to
postulate that analyzing blood levels of pituitary hor-
mones may reflect possible alterations of the limbic sys-
tem functioning in individuals with autism [29].
In the current study, serum cortisol levels were lower
and plasma ACTH levels were higher in individuals with
autism, compared to normal subjects with 10% and 16%
having low cortisol and high ACTH respectively. In
addition, 10% did not show adequate cortisol response
to ACTH stimulation. Serum cortisol and ACTH levels
were analyzed in several studies but the results were
inconsistent. Marinovic-Curin and co-workers [21]
found lower cortisol, higher ACTH and inadequate cor-
tisol response after ACTH stimulation among their
autistic patients in comparison to controls which goes
with our results. Other studies that did not perform an
ACTH stimulation test did not find a difference in corti-
sol levels among autistic patients and controls [22,30]
with only ACTH being significantly higher among cases
than controls [30] or found significantly lower cortisol
levels among autistic patients than controls [31]. In
addition, Tani and associates [32] found lower cortisol
and higher ACTH levels among patients with Asperger
syndrome than controls. The difference between our
findings and other studies could reflect variations in
methods for hormone measurement. Also, our samples
were collected in an earlier time period (9 am) and lar-
ger numbers of autistics and controls took part in our
study compared to previous reports.
Cortisol has an important role in proper emotional
development and functioning. Thus, abnormal cortisol
levels were found in chronic depression and suicide
prone behaviour [33]. In addition, lower levels of corti-
sol were found among holocaust victims with posttrau-
matic stress disorder and were pointer to “vulnerability”
for its development [34]. Also, primary disorders of cor-
tisol metabolism (Cushing syndrome and Addison dis-
ease), as well as cortisol supplement therapy are often
associated with emotional disturbances [35]. Our finding
of lower cortisol levels among individuals with autism is
hard to interpret. Some authors hypothesized that indi-
viduals with autism display heightened response to
stressors, namely venipuncture procedure so that anxiety
and situational stress could explain the raised ACTH
values [30] but elevated ACTH in our study was accom-
panied by lower cortisol levels which is in contradiction
to such a conclusion. Also, the stress of venipuncture
procedure was the same in both groups and so, the
observed differences may be related to autism pathophy-
siology rather than to acute stress. There are many stu-
dies of the plasma levels of B-endorphin in autistic
patients and most of them found higher levels of this
hormone in individuals with autism [36-38]. Since
ACTH and B-endorphin are secreted in equi-molar
quantities from same precursor, pro-opiomelanocortin,
from the anterior pituitary, other studies [30,36] show-
ing elevated B-endorphin levels in autistic individuals
support our finding of elevated ACTH. Finally, we
hypothesize that lower cortisol and higher ACTH levels
may signal a state of low basal functioning of HPA axis
in autistic individuals. This was confirmed in our study
by failure of 10% of autistic patients to show an ade-
quate cortisol response to ACTH stimulation which was
supported by another study [21]. Suggested mechanisms
include either an abnormality in delivery of ACTH to
adrenal cortex receptors, or in biosynthesis of cortisol,
or in negative feedback inhibition of HPA axis by corti-
sol and ACTH [30-32]. This hypothesis also, sheds light
on the fact that HPA axis dysfunction might have a role
in the pathophysiology of autism and its clinical sympto-
matology especially impaired behavioral and social inter-
actions [21].
Moreover, the current study revealed significantly
lower morning basal cortisol, higher ACTH and lower
cortisol response after ACTH stimulation as the autistic
severity increased. In addition, CARS score correlated
positively with ACTH and negatively with each of basal
and stimulated cortisol. This means that the extent of
the HPA axis dysfunction was closely linked to autistic
severity which was confirmed by another study [30].
In the current study, all hormonal parameters did not
differ significantly according to the IQ of autistic sub-
jects. Similarly, Marinovic-Curin etal, 2003 [21] and
Figure 1 Correlation between ACTH stimulated cortisol and
autistic severity assessed by CARS.
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appear to influence the hormonal levels significantly
b e a r i n gi nm i n dt h a tt h e yd i dn o tc o n f i r mt h e i rr e s u l t s
by performing an ACTH stimulation test. To the best of
our knowledge, we could not trace data in literature to
explain the mechanism by which low plasma cortisol
could affect cognitive functions in autistic children. On
the other hand, another study [39] concluded that, gen-
erally speaking, increased cortisol levels due to stress-
induced HPA axis over activity have been associated
with cognitive impairment as stress-induced HPA axis
overactivity and increased cortisol levels may cause hip-
pocampal damage and, subsequently, cognitive decline.
Furthermore, patients with Cushing’ss y n d r o m em o r e
often present with cognitive impairment [40]. Finally,
one of the side-effects of treatment with synthetic corti-
costeroids is cognitive deterioration [41]
Also, the current study revealed that hormonal profile
did not differ significantly between autistic children with
and without EEG abnormalities which was also sup-
ported by Marinovic-Curin and associates [21].
In addition, the current study demonstrated that hor-
monal profile did not significantly differ between autistic
patients with and without self injurious behavior which
was also confirmed by another study [21]. Inspite of the
previous fact, there is evidence of an association
between low HPA axis activity and antisocial behavior
since cortisol, which is the final product of the HPA
axis, is an important factor for proper emotional and
social development and functioning [42,43].
Conclusions
In conclusion, the observed hormonal changes may be
due to a dysfunction in the HPA axis in autistic indivi-
duals. Further studies are warranted regarding the role
of HPA axis dysfunction in the pathogenesis of autism.
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